Figure 2 — Baicalein attenuates OVA-induced allergic airway inflammation through the inhibition of the NF-κB signaling pathway

Research Paper|Volume 11, Issue 21|pp. 9310–9327

Baicalein attenuates OVA-induced allergic airway inflammation through the inhibition of the NF-κB signaling pathway

100%

Figure 2.Baicalein reduces OVA-induced Th2 inflammation. The OVA/Al(OH)₃ model is characterized by Th2-driven airway inflammation. To determine the effect of Baicalein on Th2 airway inflammation, ELISA was performed to detect the levels of IgE in serum (A) and IL-4, IL-5, and IL-13 in BALF (B–D) and lung homogenate (E–G) (results are presented as the mean ± SEM. n = 6 mice per group; ^##P < 0.01 compared with the control group; *P < 0.05, **P < 0.01 compared with the OVA/Vehicle group).